Entering text into the input field will update the search result below

Supernus Pharma ups revenue guidance after Q2 results

Aug. 11, 2014 6:16 PM ETSupernus Pharmaceuticals, Inc. (SUPN) StockBy: Douglas W. House, SA News Editor
  • Supernus Pharmaceuticals (NASDAQ:SUPN -1.8%) Q2 results: Revenues: $29.7M (+999%); Operating Income: $3.8M (+124.3%); Net Income: $3.2M (+111.7%); EPS: $0.08 (+109.0%); Quick Assets: $47.3M (-42.5%).
  • 2014 Guidance: Revenue: ~$105M; cash burn: $5M - 10M; quick assets at year end: $75M - 85M; net income: >$0.
  • 2015 Guidance: Cash flow positive.

Recommended For You

More Trending News

About SUPN Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
SUPN--
Supernus Pharmaceuticals, Inc.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.